Travere Therapeutics, Inc.
TVTX stock score: 51/100
$52.58 · +0.54% · Scored Oct 21, 2026
- Technical
- 61
- Fundamental
- 41
- News
- 52
The reading
Travere Therapeutics (TVTX) scores 51 out of 100, which reads neutral, higher than 64% of Healthcare stocks and 45% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 61, fundamentals 41.
Among the fundamentals, Price Target at 100 and Quick Ratio at 98 score highest, while Institutional Ownership at 0 weighs the most against it.
On the daily chart, trend-following indicators average 40 and contrarian oscillators 64.
News sentiment is neutral at 52; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 48 to 74, and it is down 19 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward TVTX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
41Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Quick Ratio98
Quick ratio measures a company's ability to meet short-term obligations with liquid assets.
- Current Ratio98
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- Institutional Ownership0
Institutional ownership measures the percentage held by professional investors.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
- EV/EBITDA0
EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.
38 weighted scorers; 3 had no data today and are left out rather than counted as zero.
Technical · daily
45Pulling it up
- 52-Week Change100
The price change over the last 52 weeks.
- S&P 500 52W Comparison98
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
- Bollinger Bands (50)87
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
Holding it back
- Performance vs SPY0
Performance versus SPY compares the stock's returns to the S&P 500 index.
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
62 weighted scorers; 3 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 52
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 56 | 1 |
| Daily | 45 | 3 |
| Weekly | 61 | 2 |
| Monthly | 74 | 2 |
| Quarterly | 74 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 21, 2026 | 51 |
| Oct 20, 2026 | 50 |
| Oct 19, 2026 | 49 |
| Oct 18, 2026 | 49 |
| Oct 17, 2026 | 49 |
| Oct 16, 2026 | 48 |
| Oct 15, 2026 | 50 |
| Oct 14, 2026 | 51 |
| Oct 13, 2026 | 50 |
| Oct 12, 2026 | 50 |
| Oct 11, 2026 | 50 |
| Oct 10, 2026 | 50 |
| Oct 9, 2026 | 49 |
| Oct 8, 2026 | 49 |
| Oct 7, 2026 | 49 |
| Oct 6, 2026 | 50 |
| Oct 5, 2026 | 51 |
| Oct 4, 2026 | 51 |
| Oct 3, 2026 | 51 |
| Oct 2, 2026 | 52 |
| Oct 1, 2026 | 50 |
| Sep 30, 2026 | 51 |
| Sep 29, 2026 | 52 |
| Sep 28, 2026 | 53 |
| Sep 27, 2026 | 52 |
| Sep 26, 2026 | 52 |
| Sep 25, 2026 | 51 |
| Sep 24, 2026 | 54 |
| Sep 23, 2026 | 54 |
| Sep 22, 2026 | 51 |
| Sep 21, 2026 | 53 |
| Sep 20, 2026 | 53 |
| Sep 19, 2026 | 53 |
| Sep 18, 2026 | 53 |
| Sep 17, 2026 | 54 |
| Sep 16, 2026 | 53 |
| Sep 15, 2026 | 53 |
| Sep 14, 2026 | 56 |
| Sep 13, 2026 | 55 |
| Sep 12, 2026 | 55 |
| Sep 11, 2026 | 55 |
| Sep 10, 2026 | 56 |
| Sep 9, 2026 | 57 |
| Sep 8, 2026 | 56 |
| Sep 7, 2026 | 55 |
| Sep 6, 2026 | 54 |
| Sep 5, 2026 | 54 |
| Sep 4, 2026 | 54 |
| Sep 3, 2026 | 56 |
| Sep 2, 2026 | 56 |
| Sep 1, 2026 | 55 |
| Aug 31, 2026 | 56 |
| Aug 30, 2026 | 55 |
| Aug 29, 2026 | 55 |
| Aug 28, 2026 | 55 |
| Aug 27, 2026 | 57 |
| Aug 26, 2026 | 57 |
| Aug 25, 2026 | 56 |
| Aug 24, 2026 | 56 |
| Aug 23, 2026 | 56 |
| Aug 22, 2026 | 56 |
| Aug 20, 2026 | 58 |
| Aug 19, 2026 | 59 |
| Aug 18, 2026 | 58 |
| Aug 17, 2026 | 59 |
| Aug 16, 2026 | 57 |
| Aug 15, 2026 | 57 |
| Aug 14, 2026 | 59 |
| Aug 13, 2026 | 58 |
| Aug 12, 2026 | 59 |
| Aug 11, 2026 | 58 |
| Aug 10, 2026 | 58 |
| Aug 9, 2026 | 59 |
| Aug 8, 2026 | 59 |
| Aug 7, 2026 | 59 |
| Aug 6, 2026 | 56 |
| Aug 5, 2026 | 57 |
| Aug 3, 2026 | 56 |
| Aug 2, 2026 | 55 |
| Jul 31, 2026 | 73 |
| Jul 30, 2026 | 74 |
| Jul 29, 2026 | 73 |
| Jul 28, 2026 | 70 |
| Jul 27, 2026 | 71 |
| Jul 26, 2026 | 70 |
| Jul 25, 2026 | 70 |
Key facts
- Market cap
- $5.0B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 1.14
- Risk grade (1–10)
- 3
- Next earnings
- Oct 29, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| ORKA Oruka Therapeutics | $5.3B | 42 |
| SRRK Scholar Rock Holding | $5.2B | 45 |
| PTCT PTC Therapeutics | $5.2B | 63 |
| ERAS Erasca | $5.1B | 45 |
| CRSP CRISPR Therapeutics AG | $4.9B | 39 |
| TNGX Tango Therapeutics | $4.5B | 55 |
Questions
What is TVTX's stock score today?
TVTX scores 51/100 (Neutral) as of Oct 21, 2026: technical 61, fundamental 41, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.
Is TVTX a buy?
The score is not a buy or sell recommendation. A 51 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the TVTX score calculated?
100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.